Cargando…

Targeted Therapies for Brain Metastases from Breast Cancer

The discovery of various driver pathways and targeted small molecule agents/antibodies have revolutionized the management of metastatic breast cancer. Currently, the major targets of clinical utility in breast cancer include the human epidermal growth factor receptor 2 (HER2) and epidermal growth fa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Venur, Vyshak Alva, Leone, José Pablo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037817/ https://www.ncbi.nlm.nih.gov/pubmed/27649142 http://dx.doi.org/10.3390/ijms17091543

Ejemplares similares

Management of Brain Metastases from Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Breast Cancer
por: McGranahan, Tresa M., et al.
Publicado: (2022)

Spotlight on nivolumab in the treatment of renal cell carcinoma: design, development, and place in therapy
por: Venur, Vyshak Alva, et al.
Publicado: (2017)

Targeting Molecular Pathways in Intracranial Metastatic Disease
por: Venur, Vyshak Alva, et al.
Publicado: (2019)

Breast cancer brain metastases: the last frontier
por: Leone, José Pablo, et al.
Publicado: (2015)

Novel Therapeutic Approaches in Neoplastic Meningitis
por: Khosla, Atulya Aman, et al.
Publicado: (2022)

The Judicious Use of Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy in the Management of Large Brain Metastases
por: Gutschenritter, Tyler, et al.
Publicado: (2020)

Advances in the Management of Central Nervous System Metastases from Breast Cancer
por: Avila, Jorge, et al.
Publicado: (2022)

Treatment of breast cancer brain metastases: radiotherapy and emerging preclinical approaches
por: Mampre, David, et al.
Publicado: (2022)

Intraocular bevacizumab in the treatment of choroidal metastases from breast cancer
por: Nadiminti, Kalyan, et al.
Publicado: (2016)

Combination of radiotherapy and targeted therapy for HER2-positive breast cancer brain metastases
por: Yang, Xiaojing, et al.
Publicado: (2023)

Central Nervous System Metastases from Triple-Negative Breast Cancer: Current Treatments and Future Prospective
por: Kadamkulam Syriac, Arun, et al.
Publicado: (2022)

Breast cancer brain metastases: new directions in systemic therapy
por: Lin, Nancy U
Publicado: (2013)

Targeted drugs for systemic therapy of lung cancer with brain metastases
por: Sun, Ya-Wen, et al.
Publicado: (2017)

Adjuvant systemic therapy in older women with breast cancer
por: Leone, Julieta, et al.
Publicado: (2016)

Management of Brain and Leptomeningeal Metastases from Breast Cancer
por: Pellerino, Alessia, et al.
Publicado: (2020)

Therapy of breast cancer brain metastases: challenges, emerging treatments and perspectives
por: Kotecki, Nuria, et al.
Publicado: (2018)

State of affairs regarding targeted pharmacological therapy of cancers metastasized to the brain
por: Steiger, Hans-Jakob, et al.
Publicado: (2022)

Melanoma Brain Metastases in the Era of Target Therapies: An Overview
por: Becco, Paolo, et al.
Publicado: (2020)

Targeted Therapies in Brain Metastases
por: Lin, Nancy U.
Publicado: (2013)

Preclinical Models of Brain Metastases in Breast Cancer
por: Knier, Natasha N., et al.
Publicado: (2022)

Brain Metastases from Lung Cancer: Is MET an Actionable Target?
por: Stella, Giulia M., et al.
Publicado: (2019)

Management of Melanoma Brain Metastases in the Era of Targeted Therapy
por: Shapiro, Daniela Gonsalves, et al.
Publicado: (2011)

Management of solitary and multiple brain metastases from breast cancer
por: Willett, Addison, et al.
Publicado: (2015)

The management of elderly patients with brain metastases from breast cancer
por: Ruiz-Garcia, Henry, et al.
Publicado: (2020)

Therapeutic targets for bone metastases in breast cancer
por: Clézardin, Philippe
Publicado: (2011)

Targeted therapy of brain metastases: latest evidence and clinical implications
por: Di Lorenzo, Rodica, et al.
Publicado: (2017)

Beyond the Barrier: Targeted Radionuclide Therapy in Brain Tumors and Metastases
por: Puttemans, Janik, et al.
Publicado: (2019)

Intracranial Response Rate in Patients with Breast Cancer Brain Metastases after Systemic Therapy
por: Niwinska, Anna, et al.
Publicado: (2022)

Dual targeting micelles loaded with paclitaxel and lapatinib for combinational therapy of brain metastases from breast cancer
por: Lu, Heng, et al.
Publicado: (2022)

Treatment strategies for breast cancer brain metastases
por: Bailleux, Caroline, et al.
Publicado: (2020)

Salvage Treatment for Progressive Brain Metastases in Breast Cancer
por: Spałek, Mateusz Jacek, et al.
Publicado: (2022)

Targeted Therapies for Melanoma Brain Metastases
por: Berghoff, Anna S., et al.
Publicado: (2017)

Rationale for the Use of Upfront Whole Brain Irradiation in Patients with Brain Metastases from Breast Cancer
por: Tallet, Agnes V., et al.
Publicado: (2014)

Intracranial Solitary Fibrous Tumor/Hemangiopericytoma Treated with Microsurgical Resection: Retrospective Cohort Analysis of a Single-Center Experience
por: Swaminathan, Shreya, et al.
Publicado: (2022)

Breast cancer brain metastases: biology and new clinical perspectives
por: Witzel, Isabell, et al.
Publicado: (2016)

Breast Cancer Brain Metastases: Clonal Evolution in Clinical Context
por: Saunus, Jodi M., et al.
Publicado: (2017)

Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases
por: Leone, Jose Pablo, et al.
Publicado: (2020)

Role of Bone Targeting Agents in the Prevention of Bone Metastases from Breast Cancer
por: D’Oronzo, Stella, et al.
Publicado: (2020)

Novel approaches to target HER2-positive breast cancer: trastuzumab emtansine
por: Recondo, Gonzalo, et al.
Publicado: (2016)

Brain Metastases in Lung Cancers with Emerging Targetable Fusion Drivers
por: Tan, Aaron C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dc0inheov7r2jb145koe9a5po7